Also, 58 out of 81 (72%) patients with tumours with high PRLR expression and 3 out of 8 (38%) patients with tumours showing low PRLR expression died during the follow-up period (P=0.023, log-rank test; Figure 4A). This evidence concerns the gene PRLR and neoplasm.